Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cystic fibrosis--controversial issues

M Ramsay1

  • 1South African Cystic Fibrosis Medical and Scientific Advisory Committee, Johannesburg.

South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|July 1, 1992
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enriching African genome representation through the AGenDA project.

Nature·2026
Same author

Right of reply - Response to: In defence of South Africa's National Health Research Ethics Council guidelines on heritable human genome editing.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2025
Same author

Heritable human genome editing in South Africa - time for a reality check.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2025
Same author

Section on heritable human genome editing withdrawn from the National Health Research Ethics Council Guidelines.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2025
Same author

Reactogenicity and immunogenicity following heterologous and homologous third dose COVID-19 vaccination in UK adolescents (Com-COV3): A randomised controlled non-inferiority trial.

The Journal of infection·2025
Same author

Estimating the potential number of cases prevented by infant/ toddler immunisation with a MenACWY vaccine.

Vaccine·2024